Mark Stejbach

Mark Stejbach

DirectoratIndivior Pharmaceuticals· In the 2025 proxy

Mark Stejbach sits on 1 public board.

Experience

  1. Indivior PharmaceuticalsPublic company · 1 yr
    • Director2025 – Present · 1 yrStock in role +190%
  2. Flexion Therapeutics, Inc. (Nasdaq: FLXN)Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?